🔎 Trials Near Me

መነሻ › Multiple Myeloma › Washington › Seattle

በSeattle፣ WA ለMultiple Myeloma የሚደረጉ ክሊኒካዊ ጥናቶች

ለMultiple Myeloma የሚደረጉ 22 ጥናቶች በSeattle እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Research Site, Seattle
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT07391657

A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • University of Washington, Seattle
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT04973605

A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • University of Washington, Seattle
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06500884

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Swedish Cancer Institute, Seattle
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT02693535

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Fred Hutchinson Cancer Research Center, Seattle
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT07648264

Response-Based Dose Reduction of Linvoseltamab in the Treatment of Relapsed, Refractory, or Triple-Class Relapsed/Refractory Multiple Myeloma

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Fred Hutch/University of Washington Cancer Consortium, Seattle
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT07181941

Collection of Tissue Samples for Cancer Research

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Fred Hutchinson, Seattle
2 Months · ሁሉም ጾታዎች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT00900198

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Fred Hutchinson Cancer Center, Seattle
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ14 ሴፕቴ 2026 · NCT06297226

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Saint Joseph Medical Center Hematology and Oncology - Silverdale, Silverdale · 17 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ19 ኦገስ 2026 · NCT04566328

AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Research Site, Seattle
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ኦገስ 2026 · NCT05850234

Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Research Site, Seattle
  • Research Site, Seattle
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ14 ኦገስ 2026 · NCT07764978

Selinexor and Backbone Treatments of Multiple Myeloma Patients

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Fred Hutch Cancer Center, Seattle
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ15 ጁላይ 2026 · NCT02343042

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Fred Hutchinson Cancer Center. /ID# 267940, Seattle
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ጁላይ 2026 · NCT05650632

A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • VA Puget Sound Health Care System, Seattle
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ጁላይ 2026 · NCT05137054

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Swedish Medical Center-Ballard Campus, Seattle
  • Swedish Medical Center-Cherry Hill, Seattle
  • Swedish Medical Center-First Hill, Seattle
  • እና 1 ተጨማሪ
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ10 ጁን 2026 · NCT05561387

Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Fred Hutchinson Cancer Center, Seattle
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ19 ሜይ 2026 · NCT06433947

Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Swedish Medical Center - Seattle /ID# 268052, Seattle
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ12 ሜይ 2026 · NCT06896916

Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Swedish Cancer Institute, Seattle
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ኤፕሪ 2026 · NCT03761108

A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Swedish Medical Center, Seattle
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ18 ማርች 2026 · NCT06153251

PRO and Wearable Data Insights From Individuals With R/R Multiple Myeloma

ተሳታዮችን በመፈለግ ላይ
  • University of Washington, Seattle
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ኤፕሪ 2025 · NCT05956457

Real World Insights During Treatment for Relapsed/Refractory Multiple Myeloma with Isatuximab

ተሳታዮችን በመፈለግ ላይ
  • University of Washington, Seattle
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ11 ዲሴም 2024 · NCT05053607

Evaluating the Uptake and Utility of Clinical Pathways for Newly Diagnosed Patients With Multiple Myeloma

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • All4Cure, Seattle
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ሜይ 2024 · NCT06149910

በሌሎች ከተሞች ለMultiple Myeloma የሚደረጉ ጥናቶች

በSeattle ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።